GoBeans.ca : New Look and Updated Content!

May 22, 2019

The Ontario Pulse Crop Committee are very pleased to announce that GoBeans.ca has been updated! The home of our annual dry bean performance testing data has a fresh, new look. Head over to GoBeans.ca to find:

Variety descriptions for many of the varieties grown in Ontario – *New Content!*
The 2018 Ontario Dry Bean Variety Trials report in PDF format, which contains multi-year performance data for all classes of dry beans grown in Ontario
Historical Ontario Dry Bean Variety Trials reports dating back to 2005
Multi-year dry bean performance data displayed in tables and graphs
Head to head dry bean variety comparison tool
Research reports and presentations on dry bean topics, prepared by Ontario researchers and extension specialists

The website has details on where performance trials are located and who manages them, distributors of dry bean varieties in Ontario, and links to other valuable resources for local dry bean producers. You can also find more information about the Ontario Pulse Crop Committee and who to contact if you have questions related to the activities of the committee.

Source : Field Crop News

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.